DRL to launch innovator brand of favipiravir, is silent on pricing

Ties up with Fujifilm for exclusive rights over Avigan for Indian market, can sell overseas too

The next favipiravir brand will be in market soon as Hyderabad-based Dr Reddy's Laboratories (DRL) on Wednesday said that it has tied up with the innovator Fujifilm to launch the brand Avigan in India. DRL has the rights to sell the drug overseas other than Japan, China and Russia. 

The company did not wish to disclose the price of the drug or by when it could launch it in the Indian market. It would be a nod from the country's drug regulator before it can launch the product for Indian market. Mumbai based Glenmark has launched the drug for Rs 103